By NOF; Wednesday, August 18, 2010

June 2009 - Support for Legislation to Protect Patient Access to Osteoporosis Testing Continues to Grow

On June 1, 2009, the National Osteoporosis Foundation (NOF), along with 34 other patient, professional, health and community organizations sent a letter to Senators Lincoln and Snowe, and Representatives Berkley and Burgess thanking them for introducing S. 769/H.R. 1894. Below is the list of organizations who signed onto the letter of support.

Alliance for Aging Research
American Association of Clinical Endocrinologists
American Bone Health
American College of Nurse Midwives
American College of Obstetricians and Gynecologists
American College of Rheumatology
American Medical Women's Association
American Orthopaedic Association
American Society for Bone and Mineral Research
Assisted Living Federation of America
Association of Reproductive Health Professionals
Association of Women’s Health, Obstetric and Neonatal Nurses
Black Women’s Health Imperative
California Hispanic Osteoporosis Foundation
Coalition of Labor Union Women
Coalition of State Rheumatology Organizations
Foundation for Osteoporosis Research and Education
Georgia Osteoporosis Initiative
International Society for Clinical Densitometry
International Society of Physical and Rehabilitation Medicine
National Association of Nurse Practitioners in Women’s Health
National Black Nurses Association
National Council of Women’s Organizations
National Medical Association
National Osteoporosis Foundation
National Resource Center
North American Menopause Society
Osteogenesis Imperfecta Foundation
Possible Woman Foundation
RetireSafe
Society for Women’s Health Research
The Endocrine Society
The Paget Foundation for Paget's Disease of Bone and Related Disorders
U.S. Bone and Joint Decade
Women in Government
Women’s Research and Education Institute

The latest

Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.

In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."

CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.